Tuesday, February 21, 2023 5:11:39 PM
Some people expect him to say what ever he is working on. That would be very detrimental towards what he would be working on, the company, himself, and all shareholders. He keeps us up on info, to a point, that he can share. I personally would like him to just drop a note once in a while to let us know that he is still working on things behind the scenes. The kind of progress he is making (not specific though), and an estimated time frame when he hopes to advise us shareholders. Even an early indication that a PR will be seen in a day or two (and follow up with said PR) so shareholders know he is alive and working on things for us. With the struggles from the government not pushing the cannabis usage through, he could be advising what they (he and others in the field) are doing to get the bills through. Contact names of the politicians so that we may make contact with them as well.
He seems to have been doing a lot for the company, but not so much for us shareholders. More communication to us, even small amounts, might help reduce the harsh criticism he has been getting from some here. That may also help to raise share structure. It definitely can't hurt.
Rip Master and a few others are trying to keep things positive, myself included. With the exception of the Market Makers that is.
I can't speak for others but I have not sold any of my shares nor do I intend to in the near future. I am here to see this ticker get some big life to it. And with what this company has, should already be half way there but it isn't. It has a long way to go. I just hope I will see it make the mark ($1.50 - $2.00) sooner rather than later, like 5 years not 20 years. I believe it will happen but don't know when.
Recent NTRR News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/15/2023 09:15:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/14/2023 08:01:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/04/2023 08:21:12 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM